Zimmer Biomet (ZBH) PT Raised to $153 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
- SanDisk upgraded at JPMorgan after investor day; shares climb
BofA Securities Upgrades Zimmer Biomet (ZBH) to Neutral (Tuesday)
May 3, 2023 9:14 AM EDTBofA Securities analyst Travis Steed upgraded Zimmer Biomet (NYSE: ZBH) from Underperform to Neutral with a price target of $160.00 (from $120.00).
For an analyst ratings summary and ratings history on Zimmer Biomet click here. For more ratings news on Zimmer Biomet click here.
Shares of Zimmer Biomet closed at $143.01 yesterday.
... More